For example, IL-2, IL-12, and IL-15 are able to drive the proliferation of effector CD8+ and CD4+ T cells in peripheral lymphoid tissues and the tumor microenvironment, thus amplifying the overall CTL response and antitumor efficacy13,14. This evidence concerns the gene CD8A and neoplasm.